---
title: GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation
  - successfully treated by extracorporeal photopheresis
date: '2024-12-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39624098/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241203172312&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: CAR T-cell therapy is highly effective, but also associated
  with unique toxicities. Because of the origin of T cells in patients who previously
  underwent allogeneic hematopoietic cell transplantation (alloHCT), graft-versus-host
  disease (GVHD) in the post-CAR T-cell setting poses a relevant concern but is only
  scarcely studied. Potential risk factors and mitigation strategies (from CAR T-cell
  modifications to clinical management) are yet to be ...'
disable_comments: true
---
INTRODUCTION: CAR T-cell therapy is highly effective, but also associated with unique toxicities. Because of the origin of T cells in patients who previously underwent allogeneic hematopoietic cell transplantation (alloHCT), graft-versus-host disease (GVHD) in the post-CAR T-cell setting poses a relevant concern but is only scarcely studied. Potential risk factors and mitigation strategies (from CAR T-cell modifications to clinical management) are yet to be ...